Tizanidne Hydrochloride
Product Images NDC 67296-1793

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 67296-1793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15 Count (67296 1793)

Label for Tizanidine 4 mg capsules, containing 15 capsules per package. The label includes the NDC number 67296-1793-7 and states Rx only. It provides lot number 143242X1 and expiration date 05/21. Manufacturer is Alkem Laboratories LTD, Mumbai, India. Distributed by Redpharm Drug, Eden Prairie, MN.*

FDA Label Image

Tiz01 (Tiz01)

Chemical structure of Tizanidine hydrochloride, showing the molecular framework including a chlorinated aromatic ring and a fused thiazole ring system bonded to an imidazoline moiety, with the hydrochloride component noted.*

FDA Label Image

Tiz02 (Tiz02)

A line graph depicting plasma Tizanidine concentration (ng/mL) over 24 hours post dosing. It compares 2 x 4 mg Tizanidine tablets and capsules administered with and without food, showing concentration peaks within approximately 2 hours and decline thereafter.*

FDA Label Image

Tiz03 (Tiz03)

A line graph showing improvement in Ashworth Score over 6 hours post-dose. It compares the effects of 16 mg tizanidine, 8 mg tizanidine, and placebo, with improvement scores plotted on the vertical axis and hours post-dose on the horizontal axis. Error bars indicate variability for each time point.*

FDA Label Image

Tiz04 (Tiz04)

A line chart comparing improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The chart shows two groups, tizanidine (mean dose 28.8 mg) with improvements below zero, and placebo with scores near zero or slightly positive.*

FDA Label Image

Tiz05new (Tiz05new)

Label for Tizanidine Hydrochloride Capsules 2 mg by Ascend Laboratories, LLC, distributed by Ascend Laboratories in Parsippany, NJ. The label states each capsule contains 2.29 mg tizanidine hydrochloride equivalent to 2 mg tizanidine base and includes storage instructions, a warning not to interchange with other tizanidine tablets, and a package size of 150 capsules. Manufacturer is Alkem Laboratories Ltd., Mumbai, India. The label also features a barcode and a designated unvarnished area for batch details and a 2D code.*

FDA Label Image

Tiz06new (Tiz06new)

Packaging label for Tizanidine Hydrochloride Capsules 2 mg, manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC. The label shows a package containing 10 capsules (1 x 10 unit dose) with a warning that these capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. The label includes storage instructions and a barcode.*

FDA Label Image

Tiz07 (Tiz07)

Label for Tizanidine Hydrochloride Capsule 2 mg (base), manufactured for Ascend Laboratories, LLC and made in India. The label includes a barcode, lot number placeholder, and expiration date placeholder, with a peel here feature. The product is prescription only (Rx Only).*

FDA Label Image

Tiz08new (Tiz08new)

Label for Tizanidine Hydrochloride Capsules 4 mg, showing the product name, strength, dosage form, and a count of 150 capsules. The label includes a warning that the capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. The label specifies Rx only and lists Ascend Laboratories, LLC as the distributor and Alkem Laboratories Ltd., Mumbai, India as the manufacturer. Storage instructions and a barcode are also visible.*

FDA Label Image

Tiz09new (Tiz09new)

Packaging label for Tizanidine Hydrochloride Capsules 4 mg, distributed by Ascend Laboratories, LLC. The label indicates the capsules come in a package of 10 (1 x 10 unit dose) and include a warning that the capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. The label also includes storage instructions, manufacturer information (Alkem Laboratories Ltd., Mumbai, India), and barcode details.*

FDA Label Image

Tiz10 (Tiz10)

Label for Tizanidine Hydrochloride Capsule 4 mg (base), manufactured for Ascend Laboratories, LLC, made in India. The label includes dosage strength, barcode, and placeholder text for lot number and expiration date.*

FDA Label Image

Tiz11new (Tiz11new)

Label for Tizanidine Hydrochloride Capsules 6 mg, showing packaging details including warnings, storage instructions, and manufacturing and distribution information. The label notes 150 capsules per container, with a red warning indicating capsules are not interchangeable with tizanidine or Zanaflex tablets. Manufactured by Alkem Laboratories, India, and distributed by Ascend Laboratories, LLC.*

FDA Label Image

Tiz12new (Tiz12new)

Tizanidine Hydrochloride Capsules 6 mg carton label displaying the product name and strength prominently. The label includes a 10-capsule count (1 x 10 unit dose), a warning that the capsules are not interchangeable with tizanidine tablets or Zanaflex tablets, and storage instructions. Manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC. Barcodes and additional text details are visible on the packaging.*

FDA Label Image

Tiz13 (Tiz13)

Label for Tizanidine Hydrochloride Capsule 6 mg (base) showing the prescription-only status. The label indicates manufacturing for Ascend Laboratories, LLC, and states the product is made in India. Includes a barcode, lot number placeholder, and expiration date placeholder.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.